Skip to main content

Table 3 Acute events and interventions

From: Evaluating the MPM III and SAPS III prognostic models in a war-affected, resource-limited setting: a prospective study from the Gaza Strip

Variables

Full cohort (N = 101)

Survivors (N = 70)

Non-survivors (N = 31)

p

Acute Events/Complications, n (%)

 Acute Kidney Injury

3 (2.97)

2 (2.85)

1 (3.22)

1.000

 Cardiac Dysrhythmia

9 (8.91)

2 (2.85)

7 (22.58)

0.003

 Intracranial Mass Effect*

30 (29.70)

14 (20.00)

16 (51.61)

0.003

 Infection

20 (19.80)

14 (20.00)

6 (19.35)

1.000

 Septic Shock

6 (5.94)

3 (4.28)

3 (9.67)

0.368

 Gastrointestinal Bleeding

15 (14.85)

12 (17.14)

3 (9.67)

0.384

 Diabetic Ketoacidosis

6 (5.94)

5 (7.14)

1 (3.22)

0.663

Interventions, n (%)

 Vasoactive Medication Administration

19 (18.81)

10 (31.25)

9 (29.03)

0.140

 Invasive Mechanical Ventilation

72 (71.28)

43 (61.42)

29 (93.54)

0.001

 Laparotomy

29 (28.71)

21 (30.00)

8 (25.80)

0.848

 Splenectomy

7 (6.93)

6 (8.57)

1 (3.22)

0.433

 Limb Amputation

4 (3.96)

2 (2.86)

2 (6.45)

0.584

 Chest Tube Insertion

35 (34.65)

28 (40.00)

7 (22.58)

0.142

 Central Venous Catheterization

55 (54.45)

32 (45.71)

23 (74.19)

0.015

 Thoracotomy

9 (8.91)

7 (10.00)

2 (6.45)

0.718

 ORIF

3 (2.97)

2 (2.86)

1 (3.22)

1.000

 Vascular Injury Repair

18 (17.82)

12 (17.14)

6 (19.35)

1.000

 Orthopedic Casting

14 (13.86)

7 (10.00)

7 (22.58)

0.120

 Analgesic Administration

75 (74.25)

54 (77.14)

21 (67.74)

0.453

 VTE Prophylaxis

67 (66.33)

48 (68.57)

19 (61.29)

0.627

 Stress Ulcer Prophylaxis

96 (95.04)

67 (95.71)

29 (93.55)

0.641

  1. *Refers to brain edema ± intracranial hemorrhage